Solid Biosciences
SLDB
69 hedge funds and large institutions have $332M invested in Solid Biosciences in 2019 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 34 increasing their positions, 12 reducing their positions, and 17 closing their positions.
183% more repeat investments, than reductions
Existing positions increased: 34 | Existing positions reduced: 12
159% more capital invested
Capital invested by funds: $128M → $332M (+$204M)
100% more funds holding in top 10
Funds holding in top 10: 2 → 4 (+2)
0.65% more ownership
Funds ownership: 4% → 4.65% (+0.65%)
4% less call options, than puts
Call options by funds: $5.44M | Put options by funds: $5.69M
7% less funds holding
Funds holding: 74 → 69 (-5)
29% less first-time investments, than exits
New positions opened: 12 | Existing positions closed: 17
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PA
Perceptive Advisors
New York
|
+$21.3M |
| 2 |
EC
EcoR1 Capital
San Francisco,
California
|
+$19M |
| 3 |
BCLSI
Bain Capital Life Sciences Investors
Boston,
Massachusetts
|
+$14.2M |
| 4 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$14.2M |
| 5 |
AG
Artal Group
Luxembourg
|
+$3.77M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$2.36M |
| 2 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$1.73M |
| 3 |
SIM
Spark Investment Management
New York
|
-$1.19M |
| 4 |
Renaissance Technologies
New York
|
-$890K |
| 5 |
ARTA
A.R.T. Advisors
New York
|
-$429K |
SLDB Hedge Fund Activity: Q3 2019 in Review
69 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Solid Biosciences (SLDB) for Q3 2019, worth a combined $332M — up 159% from $128M a quarter earlier.
Sellers outnumbered buyers: 17 funds closed out of SLDB and 12 opened new positions — a net loss of 5 holders — while 12 trimmed existing stakes and 34 added.
The largest buyer was Perceptive Advisors, adding an estimated $21.3M. The largest seller was Deutsche Bank, cutting an estimated $2.36M.
- 69 institutional investors held Solid Biosciences (SLDB) as of Q3 2019, down from 74 in Q2 2019.
- Funds reported $332M of Solid Biosciences stock for Q3 2019, up 159% quarter-over-quarter.
- 12 funds opened new Solid Biosciences positions in Q3 2019 and 17 closed out, a net change of -5 holders.
- The largest Solid Biosciences buyer in Q3 2019 was Perceptive Advisors, an estimated $21.3M added.
- The largest Solid Biosciences seller in Q3 2019 was Deutsche Bank, an estimated $2.36M sold.
Based on aggregated 13F filings for Q3 2019.